Stock ATE ANTIBE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Antibe Therapeutics Inc.

Equities

ATE

CA0370255097

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Antibe Therapeutics : NOTICE TO CLAIMANTS OF ANTIBE THERAPEUTICS INC. (“ANTIBE”)
PU
Antibe Announces Appointment of Receiver
BU
ANTIBE PROVIDES UPDATE ON CCAA PROCEEDINGS
AQ
Antibe Provides Update on CCAA Proceedings
BU
Antibe Announces TSX Delisting Review
BU
ANTIBE TO FILE AN APPLICATION FOR AN INITIAL ORDER UNDER COMPANIES CREDITORS ARRANGEMENT ACT
AQ
Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
BU
DELETED: Canadian Investment Regulatory Organization Trade Resumption - ATE
AQ
Canadian Investment Regulatory Organization Trading Halt - ATE
AQ
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
BU
Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
BU
Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting
BU
Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
BU
Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma
BU
Antibe Reports Q3 2024 Interim Financial and Operating Results
BU
Antibe Extends Early Warrant Exercise Incentive Program
BU
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)
AQ
Antibe Announces Early Warrant Exercise Incentive Program
BU
Antibe Therapeutics Announces Amendment to Warrant Terms
BU
Antibe Reports Q2 2024 Interim Financial and Operating Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATE Stock
  4. News Antibe Therapeutics Inc.
  5. Press Releases